Literature DB >> 17309963

Association between venous thromboembolism and perioperative allogeneic transfusion.

Kent R Nilsson1, Sean M Berenholtz, Elizabeth Garrett-Mayer, Todd Dorman, Michael J Klag, Peter J Pronovost.   

Abstract

HYPOTHESIS: Perioperative allogeneic blood product transfusion would be associated with venous thromboembolic complications in surgical patients.
DESIGN: Observational study using a state discharge database.
SETTING: Nonfederal acute care hospitals in Maryland performing colorectal cancer resections between January 1, 1994, and December 31, 2000. PATIENTS: We obtained data on 14 014 adult patients having a primary diagnosis code for colorectal cancer and a primary procedure code for colorectal resection. MAIN OUTCOME MEASURES: The primary outcome variable was a discharge diagnosis of venous thromboembolism (VTE).
RESULTS: Venous thromboembolism occurred in 1% of patients and was associated with an adjusted 3.8-fold increase in mortality (odds ratio, 3.8; 95% confidence interval, 2.1-6.8), a 61% increase in mean hospital length of stay, and a 72% increase in mean total hospital charges. Risk factors for VTE after adjustment included transfusion, female sex, age 80 years or older, moderate to severe liver disease vs no liver disease, admission through the emergency department, and low annual surgeon case volume. Transfusion was associated with an increase in the odds of developing VTE in women (odds ratio, 1.8; 95% confidence interval, 1.2-2.6) but not in men (odds ratio, 0.9; 95% confidence interval, 0.5-1.9). In the absence of transfusion, female compared with male sex was not associated with an increased risk of VTE (odds ratio, 1.2; 95% confidence interval, 0.8-1.7).
CONCLUSIONS: In this large observational study of patients undergoing colorectal cancer resection, perioperative allogeneic blood transfusion was associated with an increased risk of VTE in women but not in men. Given the substantial morbidity and mortality associated with VTE and the implication that this finding has for postoperative management in women, this association must be confirmed in independent studies.

Entities:  

Mesh:

Year:  2007        PMID: 17309963     DOI: 10.1001/archsurg.142.2.126

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  15 in total

1.  New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells.

Authors:  Katie Grimshaw; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

2.  Aggressive red blood cell transfusion: no association with improved outcomes for victims of isolated traumatic brain injury.

Authors:  Mark E George; David E Skarda; Charles R Watts; Hoai D Pham; Greg J Beilman
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  Venous thromboembolism in colorectal surgery: skip SCIP or comply?

Authors:  H H Erem; R P Kiran; F H Remzi; J D Vogel
Journal:  Tech Coloproctol       Date:  2014-02-22       Impact factor: 3.781

Review 4.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

Review 5.  Perioperative anemia management in colorectal cancer patients: a pragmatic approach.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Elisa Martín-Montañez; Michael Auerbach
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

6.  Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Authors:  Sherry L Spinelli; Katie L Lannan; Ann E Casey; Amanda Croasdell; Timothy M Curran; Kelly F Henrichs; Stephen J Pollock; Ginger A Milne; Majed A Refaai; Charles W Francis; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2013-11-05       Impact factor: 3.157

7.  Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates.

Authors:  Bérangère Devalet; Adeline Wannez; Nicolas Bailly; Lutfiye Alpan; Damien Gheldof; Jonathan Douxfils; Véronique Deneys; Benoît Bihin; Bernard Chatelain; Jean-Michel Dogné; Christian Chatelain; François Mullier
Journal:  Blood Transfus       Date:  2017-03-09       Impact factor: 3.443

8.  One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty.

Authors:  Fiona E Ralley; Donna Berta; Valerie Binns; James Howard; Douglas D R Naudie
Journal:  Clin Orthop Relat Res       Date:  2010-01-09       Impact factor: 4.176

9.  Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.

Authors:  Alok A Khorana; Charles W Francis; Neil Blumberg; Eva Culakova; Majed A Refaai; Gary H Lyman
Journal:  Arch Intern Med       Date:  2008-11-24

10.  Intra-operative blood transfusion significantly increases the risk of post-operative pulmonary embolism.

Authors:  Qiaojun Zeng; Shufang Tan; Qiang Bao; Shanping Jiang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.